Male Infertility Market Size, Share & Trends Analysis Report By Product (ART, Artificial Insemination, Fertility Surgery, Fertility Drugs), By Applications (Fertility Clinics, Hospitals, Research Banks), By End Use, By Region, and Segment Forecasts - 2035

MALE INFERTILITY MARKET REPORT OVERVIEW

male infertility market Size was estimated at 4123.35 USD million in 2025, The industry is projected to grow from 4494.04 USD million in 2026 to 5818.31 USD million by 2035, exhibiting a compound annual growth rate (CAGR) of 8.99% during the forecast period 2026 - 2035.

It is expected that from now onwards the modern male infertility market will undergo quality changes due to various reasons including but not limited to changes in daily living, high-stress levels, environmental issues, and increased disorders which hinder getting babies for instance hormonal imbalance or being overweight.

There are various reasons affecting the male infertility market; this includes increase in the incidences of male infertility across the globe, changes in lifestyles and delayed parenthood among other things. Inactivity, poor diet and environmental contaminants have been common lifestyle choices which reduced both sperm count and quality. Consequently, many individuals are now more cognizant of these implications thus leading to higher demand for measures that can treat such conditions.

The United States remains the largest contributor to the North American male infertility market due to advanced reproductive healthcare infrastructure, high adoption of assisted reproductive technologies, and expanding diagnostic capabilities. Approximately 1 in 8 couples in the U.S. experience infertility, with male factors contributing to nearly 50% of cases. More than 500 fertility clinics operate nationwide, while over 330 IVF centers provide specialized male fertility services. Increasing adoption of AI-assisted semen analysis, genetic screening, and minimally invasive sperm retrieval procedures continues to improve diagnosis. FDA-cleared diagnostic technologies and rising awareness among men aged 25–45 are strengthening demand for laboratory testing, fertility preservation, and personalized treatment services.

• • 

    Download Free sample to learn more about this report.

COVID-19 Impact: Impact of Covid Disease on Sperm Concentration Led To Increased Demand

The COVID-19 pandemic has been unprecedented and staggering, with male infertility markets experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels once the pandemic is over.

The male infertility market has been greatly influenced by the COVID-19 pandemic due to studies that show sperm count and quality may be affected by SARS-CoV-2. Men infected with the virus have shown decreased spermatogenic elements, thus attracting apprehensions about future reproductive abilities. This has subsequently led to a rise in male fertility assessments and treatments as men aim at understanding and addressing potential fertility issues. Moreover, the COVID-19 pandemic has made people more aware of reproductive health thus increasing interests in support of male infertility and resultant market growth.

LATEST TRENDS

"DNA Fragmentation Test is a Latest Trend in the Market"

A significant trend in males who are unable to conceive is the use of DNA fragmentation testing which provides an analysis of the sperm’s quality beyond that offered by traditional methods. The DNA fragmentation test checks how well intact sperm are and highlights any possible genetic damage that may interfere with fertilisation or the growth of embryos. As a result, due to rising knowledge regarding reproductive male genetics, an increasing number of couples have chosen this modern diagnostic technique. It improves the results of assisted reproductive technologies by helping physicians customise their treatment approaches using tests on DNA fragmentation. There is an upward trajectory for this kind of test thereby indicating the movement towards individuality within the framework of male reproductive health.

• • 

    Download Free sample to learn more about this report.

MALE INFERTILITY MARKET SEGMENTATION

By Type

Depending on the global male infertility market given are types: ART, Artificial Insemination, Fertility Surgery, Fertility Drugs & Others.

ART: Compared to the traditional methods, the Assisted Reproductive Technology is made up of more sophisticated technologies used for conception. For instance, some of the methods included in this category include; In Vitro Fertilisation (IVF) and Intracytoplasmic Sperm Injection (ICSI).

Artificial Insemination: Artificial Insemination is a process where a sperm is directly placed in a woman's reproductive tract.

Fertility Surgery: Fertility Surgery is a surgical process where problems such as blockages in the reproductive system are removed

Fertility Drugs: These medications are specifically made for boosting sperm production and enhancing the general reproductive health.

Others: There are other ways to tackle infertility in males such as therapies, supplements and lifestyle changes.

By Downstream Industry

The market is divided into Fertility Clinics, Hospitals & Research Banks.

Fertility Clinics: Fertility clinics are the specialised centres where the problems related to infertility are diagnosed and proper treatment is provided.

Hospitals: Hospitals provide general healthcare facilities offering comprehensive reproductive health services, including fertility treatments and surgeries.

Research Banks: The research banks involved in storing and studying biological samples, including sperm, for research purposes, which can contribute to advancements in fertility treatments

DRIVING FACTORS

"Rising Incidences of Male Infertility Globally Drive Growth in Market"

The rising incidences of male infertility globally is one of the reasons driving the male infertility market growth. Man’s declining fertility is brought about by lifestyle changes, increasing stress levels, environmental toxins and underlying health conditions. The rise in infertility cases has made people more informed, leading to greater need for diagnostic tests, treatments and advanced reproductive technologies. With numerous men looking for ways to deal with infertility, there is an expansion in the fertility clinics and specific therapies that would help tackle these problems. This has shown that it calls for urgent measures on this emerging issue of public health.

"Changing Lifestyle and Delaying Parenthood Increases the Market Demand"

Another important reason driving the market is the changing lifestyle and delaying parenthood. Contemporary way of life generally embraces heightened duress, unhealthy alimentation, inactivity and vulnerability to toxic substances in the surroundings which influence adversely on men’s capacity to reproduce. Furthermore, later in life as compared to their earlier decades when their ability for procreation is deteriorating, a good number of couples are opting for parenthood. As a result of this transition, there is an increased dependence on fertility treatments and support for reproduction by technology thereby leading to the market expansion due to desire for medical help in having children and tackling age-linked issues with reproduction.

RESTRAINING FACTORS

"High Cost of Infertility Treatments Hamper the Market Growth"

One limiting factor affecting the male infertility market is the high cost of the infertility treatments which is not affordable to the majority of people. Quite a few medically complex procedures including ICSI or IVF, in addition to related drugs or diagnostic tests, can be enormously costly. As such, some individuals are unable to afford them hence hindering the market expansion while reducing the chances for total fertility care.

• • 

    Download Free sampleto learn more about this report.

MALE INFERTILITY MARKET REGIONAL INSIGHTS

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America and Middle East & Africa.

"North America to Dominate the Market due to Rise in Awareness of Availability of Infertility Healthcare Infrastructure"

The market in Europe is the most dominant region and male infertility market share as well as exhibiting very high profitability. Predictions show that North America will be the leading region in terms of male infertility market owing to increased knowledge of infertility problems and improved medical facilities within its boundaries. Greater public awareness campaigns and education activities have made more people acknowledge that male infertility is a serious issue regarding health. Moreover the region has up-to-the minute hospitals, fertility centres which are specialised and a rising percentage of advanced reproductive technologies adoption. The combination of these factors together with suitable insurance schemes might support financing for infertility medications have made North America a prominent player in the field of male infertility management.

KEY INDUSTRY PLAYERS

"Key Players Focus on Partnerships to Gain a Competitive Advantage "

The male infertility market is significantly influenced by key industry players that play a pivotal role in driving market dynamics and shaping consumer preferences. These key players possess extensive retail networks and online platforms, providing consumers with easy access to a wide variety of treatment options. Their strong global presence and brand recognition have contributed to increased consumer trust and loyalty, driving product adoption. The collective efforts of these major players significantly impact the competitive landscape and future trajectory of the market.

List of Market Players Profiled

• The Cooper Companies, Inc. (U.S.)
• Merck & Co., Inc. (U.S.)
• Thermo Fisher Scientific (U.S.)
• Ferring Pharmaceuticals (Switzerland)
• Monash IVF (Australia)
• CCRM (Colorado Center for Reproductive Medicine) (U.S.)

INDUSTRIAL DEVELOPMENT

March 2024: Researchers have developed lab-grown testicles from immature testicular cells. New developments can address concerns about decreasing fertility and can help increase options for LGBTQ and older couples.

Five Recent Developments (2023-2025)

• 2025: Conduit Pharmaceuticals entered a strategic partnership with Sarborg Limited to advance male infertility treatment candidates and accelerate clinical development for reproductive health therapies.
• 2025: Ferring Pharmaceuticals expanded access to fertility care by strengthening collaborations with reproductive medicine centers and supporting advanced assisted reproductive technology (ART) treatment programs worldwide.
• 2024: SCSA Diagnostics enhanced its sperm DNA fragmentation testing portfolio, improving diagnostic precision for male infertility assessment and supporting fertility specialists with advanced laboratory tools.
• 2024: Vitrolife Group expanded its reproductive medicine portfolio through new fertility laboratory technologies and male fertility diagnostic solutions designed to improve IVF and ICSI outcomes.
• 2023: Halotech DNA introduced expanded sperm DNA integrity testing solutions, enabling fertility clinics to improve male infertility diagnosis and personalized treatment planning using advanced genetic assessment methods.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.